Genentech's Immunology/Infectious Disease Deal Maker On Following The Science

 
• By Jo Shorthouse
Miniature people
Genentech had been closely monitoring the microbiome space for “at least four years” before a deal was struck • Source: Shutterstock

More from Deals

More from Business